BCL2L1 and osteosarcoma: MCL-1 expression has also been associated with resistance to agents targeting BCL-2 and/or BCL-xL [45–47], however the osteosarcoma cells survived dual ABT-199/A-1331852 exposure regardless of their MCL-1 expression levels (Fig. 1).